creatine has been researched along with Child Mental Disorders in 6 studies
Excerpt | Relevance | Reference |
---|---|---|
"Even though the diagnostic yield of urine creatine metabolite panel is low, it can successfully detect CCDD patients, despite many neurodevelopmental disorders are not a result of CCDD." | 7.96 | Urine creatine metabolite panel as a screening test in neurodevelopmental disorders. ( Bahl, S; Cordeiro, D; MacNeil, L; Mercimek-Andrews, S; Schulze, A, 2020) |
" We illustrate these limitations of norm-referenced scores, and relative advantages of ability scores, using data from studies of autism spectrum disorder and creatine transporter deficiency." | 3.96 | Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders. ( Akshoomoff, N; Anselm, I; Barshop, BA; Bennett, A; Berry, L; Berry-Kravis, E; Bianconi, S; Bruchey, A; Cecil, KM; Davis, RJ; Farmer, CA; Ficicioglu, C; Goin-Kochel, RP; Guthrie, W; Kaat, AJ; Koeberl, D; Leonczyk, C; Love-Nichols, J; Mamak, E; Mercimek-Andrews, S; Miller, JS; Porter, FD; Spiridigliozzi, GA; Sullivan, N; Sutton, VR; Thomas, RP; Thurm, A; Udhnani, MD; Wainer, A; Waisbren, SE, 2020) |
"Even though the diagnostic yield of urine creatine metabolite panel is low, it can successfully detect CCDD patients, despite many neurodevelopmental disorders are not a result of CCDD." | 3.96 | Urine creatine metabolite panel as a screening test in neurodevelopmental disorders. ( Bahl, S; Cordeiro, D; MacNeil, L; Mercimek-Andrews, S; Schulze, A, 2020) |
"In healthy term newborns with chorioamnionitis, MRS ratios shortly after birth may provide evidence of occult neuroinflammation, which may be associated with worse performance on 1-year neurodevelopmental tests." | 1.42 | Proton magnetic resonance spectroscopy and outcome in term neonates with chorioamnionitis. ( Bentzley, JP; Brown, T; Hope, K; Jenkins, DD; Johnson, CB; Katikaneni, LD; Lambert, D; Morgan, PS; Mulvihill, DM; Ramakrishnan, V; Rollins, LG, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Passi, GR | 1 |
Pandey, S | 1 |
Devi, ARR | 1 |
Konanki, R | 1 |
Jain, AR | 1 |
Bhatnagar, S | 1 |
Tripathi, R | 1 |
Jain, V | 1 |
Farmer, CA | 1 |
Kaat, AJ | 1 |
Thurm, A | 1 |
Anselm, I | 1 |
Akshoomoff, N | 1 |
Bennett, A | 1 |
Berry, L | 1 |
Bruchey, A | 1 |
Barshop, BA | 1 |
Berry-Kravis, E | 1 |
Bianconi, S | 1 |
Cecil, KM | 1 |
Davis, RJ | 1 |
Ficicioglu, C | 1 |
Porter, FD | 1 |
Wainer, A | 1 |
Goin-Kochel, RP | 1 |
Leonczyk, C | 1 |
Guthrie, W | 1 |
Koeberl, D | 1 |
Love-Nichols, J | 1 |
Mamak, E | 1 |
Mercimek-Andrews, S | 2 |
Thomas, RP | 1 |
Spiridigliozzi, GA | 1 |
Sullivan, N | 1 |
Sutton, VR | 1 |
Udhnani, MD | 1 |
Waisbren, SE | 1 |
Miller, JS | 1 |
Bahl, S | 1 |
Cordeiro, D | 1 |
MacNeil, L | 1 |
Schulze, A | 1 |
Hyodo, R | 1 |
Sato, Y | 1 |
Ito, M | 1 |
Sugiyama, Y | 1 |
Ogawa, C | 1 |
Kawai, H | 1 |
Nakane, T | 1 |
Saito, A | 1 |
Hirakawa, A | 1 |
Kidokoro, H | 1 |
Natsume, J | 1 |
Hayakawa, M | 1 |
Barta, H | 1 |
Jermendy, A | 1 |
Kolossvary, M | 1 |
Kozak, LR | 1 |
Lakatos, A | 1 |
Meder, U | 1 |
Szabo, M | 1 |
Rudas, G | 1 |
Johnson, CB | 1 |
Jenkins, DD | 1 |
Bentzley, JP | 1 |
Lambert, D | 1 |
Hope, K | 1 |
Rollins, LG | 1 |
Morgan, PS | 1 |
Brown, T | 1 |
Ramakrishnan, V | 1 |
Mulvihill, DM | 1 |
Katikaneni, LD | 1 |
6 other studies available for creatine and Child Mental Disorders
Article | Year |
---|---|
Cerebral creatine deficiency disorders - A clinical, genetic and follow up study from India.
Topics: Brain Diseases, Metabolic, Inborn; Child; Child, Preschool; Creatine; Female; Follow-Up Studies; Gua | 2022 |
Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders.
Topics: Autism Spectrum Disorder; Brain Diseases, Metabolic, Inborn; Child; Creatine; Humans; Mental Retarda | 2020 |
Urine creatine metabolite panel as a screening test in neurodevelopmental disorders.
Topics: Brain Diseases, Metabolic, Inborn; Canada; Creatine; Female; Guanidinoacetate N-Methyltransferase; H | 2020 |
Magnetic resonance spectroscopy in preterm infants: association with neurodevelopmental outcomes.
Topics: Aspartic Acid; Brain; Child Development; Choline; Creatine; Female; Humans; Infant; Infant, Newborn; | 2018 |
Prognostic value of early, conventional proton magnetic resonance spectroscopy in cooled asphyxiated infants.
Topics: Aspartic Acid; Brain; Creatine; Epilepsy; Female; Hearing Loss; Hospital Mortality; Humans; Hypother | 2018 |
Proton magnetic resonance spectroscopy and outcome in term neonates with chorioamnionitis.
Topics: Basal Ganglia; Brain; Choline; Chorioamnionitis; Creatine; Dipeptides; Female; Healthy Volunteers; H | 2015 |